Multiple Sclerosis: Shall We Target CD33?

Multiple Sclerosis: Shall We Target CD33?

Background: Multiple sclerosis (MS) is a chronic disease of the central nervous system (CNS). Myeloid lineage cells (microglia and macrophages) may participate in the pathogenic mechanisms leading to MS. CD33 is a transmembrane receptor, mainly expressed by myeloid lineage cells. CD33 rs3865444 is a...

Full description

Bibliographic Details
Main Authors: Vasileios Siokas, Zisis Tsouris, Athina-Maria Aloizou, Christos Bakirtzis, Ioannis Liampas, Georgios Koutsis, Maria Anagnostouli, Dimitrios P. Bogdanos, Nikolaos Grigoriadis, Georgios M. Hadjigeorgiou, Efthimios Dardiotis
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Genes
Subjects:
multiple sclerosis
CD33
single nucleotide polymorphism
genetics
rs3865444
Online Access:https://www.mdpi.com/2073-4425/11/11/1334

Internet

https://www.mdpi.com/2073-4425/11/11/1334

Similar Items